We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
10 Year Est. Return
AUM
$582M
AUM Growth
+$172M
Cap. Flow
+$166M
Cap. Flow %
28.59%
Top 10 Hldgs %
56.7%
Holding
46
New
13
Increased
16
Reduced
9
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 81.08%
2 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRO
1
DELISTED
NEVRO CORP.
NVRO
$54.1M 9.29%
1,006,479
+482,743
+92% +$24.6M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$35.1B
$51.9M 8.91%
877,497
+326,300
+59% +$20.1M
LH icon
3
Labcorp
LH
$23.1B
$51.3M 8.8%
492,256
+295,540
+150% +$30.8M
STJ
4
DELISTED
St Jude Medical
STJ
$41.1M 7.06%
562,700
-170,900
-23% -$12.3M
PRGO icon
5
Perrigo
PRGO
$1.45B
$36.6M 6.29%
+198,100
New +$37.8M
CNCE
6
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$23.2M 3.98%
1,557,534
+441,434
+40% +$6.72M
BDX icon
7
Becton Dickinson
BDX
$42.2B
$20.8M 3.57%
+150,573
New +$20.8M
TVTY
8
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$17.3M 2.96%
+1,440,503
New +$23.9M
RCPT
9
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$17.1M 2.93%
89,800
+21,400
+31% +$3.54M
MDT icon
10
Medtronic
MDT
$105B
$16.9M 2.91%
+228,400
New +$17.5M
JNJ icon
11
Johnson & Johnson
JNJ
$615B
$16.7M 2.87%
+171,400
New +$17.2M
VTRS icon
12
Viatris
VTRS
$19.8B
$15.9M 2.72%
+233,784
New +$16.5M
ESPR
13
DELISTED
Esperion Therapeutics
ESPR
$12.6M 2.16%
+153,900
New +$15.1M
MDXG icon
14
MiMedx Group
MDXG
$621M
$12.5M 2.15%
1,080,559
-1,021,500
-49% -$10.5M
CI icon
15
Cigna
CI
$75.4B
$12.4M 2.12%
+76,300
New +$10.5M
ELOS
16
DELISTED
Syneron Medical Ltd
ELOS
$12.1M 2.08%
1,141,700
+18,800
+2% +$220K
OFIX icon
17
Orthofix Medical
OFIX
$445M
$11.9M 2.05%
360,001
+16,800
+5% +$578K
KND
18
DELISTED
Kindred Healthcare
KND
$11.7M 2.01%
576,876
-1,059,724
-65% -$24.3M
DYAX
19
DELISTED
DYAX CORPORATION
DYAX
$11.7M 2%
+440,433
New +$11.7M
INSM icon
20
Insmed
INSM
$23.1B
$11.3M 1.95%
464,307
-74,800
-14% -$1.7M
CORI
21
DELISTED
Corium International, Inc.
CORI
$11.1M 1.91%
813,085
-201,735
-20% -$2.28M
SGNT
22
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$11M 1.89%
453,392
+35,700
+9% +$855K
XNPT
23
DELISTED
XENOPORT, INC.
XNPT
$10.6M 1.81%
1,722,100
+265,200
+18% +$1.74M
TNDM icon
24
Tandem Diabetes Care
TNDM
$1.16B
$9.32M 1.6%
85,955
+30,356
+55% +$3.78M
AET
25
DELISTED
Aetna Inc
AET
$8.41M 1.44%
+66,000
New +$7.54M

Similar funds

Senzar Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Senzar Asset Management held 46 positions worth $582M, up 42% from $410M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Senzar Asset Management deployed $166M of net new capital in Q2 2015, opening 13 new positions and adding to 16 existing holdings. Its largest new stake was Perrigo: 198,100 shares worth $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 83% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Kindred Healthcare, an estimated $24.3M trimmed.

  • Senzar Asset Management's largest Q2 2015 buy was Perrigo: 198,100 shares worth $36.6M.
  • Senzar Asset Management added most to Labcorp in Q2 2015, an estimated $30.8M increase.
  • Senzar Asset Management's biggest Q2 2015 reduction was Kindred Healthcare, cutting an estimated $24.3M.
  • Senzar Asset Management fully exited Sanofi in Q2 2015, selling an estimated $23.7M.
  • Senzar Asset Management's ten largest holdings make up 57% of its $582M portfolio in Q2 2015.
  • Senzar Asset Management opened 13 new positions and closed 8 in Q2 2015.
  • Senzar Asset Management's portfolio value rose 42% quarter-over-quarter to $582M.

Based on Senzar Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.